Companies / Ionis Pharmaceuticals Inc
Ionis Pharmaceuticals Inc
Nasdaq: IONSCIK 874015CARLSBAD, CA
Insider flow · last 90 daysNet sells $1.19M
Financials · FY2025
Ownership
166.2M shares outstanding · as of Jul 23, 2026
Ownership
| Insiders | 0.60% | 997,018 |
| 10%+ / strategic | 5.48% | 9,108,019 |
| Institutions | 101.70% | 169,001,442 |
| Public float | 0.00% | 0 |
Reported holdings exceed shares outstanding — public float shown as 0; some positions may overlap or lag.
% of common shares outstanding (exact, from the latest cover-page filing). Institutions are quarterly 13F snapshots; insiders reflect current officers & directors.
Insiders 17
View all →| Insider | % of shares | Shares |
|---|---|---|
Monia Brett PCEOChief Executive Officer · Director | 0.15% | 242,662 |
Berthelsen Spencer RDirector | 0.09% | 156,013 |
Hougen Elizabeth LEVP, Finance & CFO | 0.05% | 82,660 |
Bennett C FrankEVP, Chief Scientific Officer | 0.05% | 80,554 |
Birchler BrianEVP, Corp and Development Ops | 0.04% | 66,598 |
Schneider EugeneEVP, Chf Clinical Develop Ofcr | 0.04% | 63,890 |
O'Neil Patrick R.EVP CLO & General Counsel | 0.04% | 62,211 |
Parshall B LynneDirector | 0.03% | 51,344 |
Baroldi JosephEVP, Chief Business Officer | 0.03% | 45,664 |
Loscalzo JosephDirector | 0.02% | 36,330 |
Institutional holders 500
View all →| Holder | Value | % of shares |
|---|---|---|
| $1.90B | 14.49% | |
| $1.42B | 10.81% | |
| $1.30B | 9.89% | |
| $848.77M | 6.44% | |
| $495.25M | 3.77% | |
| $439.85M | 3.52% | |
| $379.90M | 2.89% | |
| $343.71M | 2.61% | |
| $305.20M | 2.40% | |
| $285.48M | 2.29% |
Activity
InsidersInstitutions
What insiders are doing in this stock (Form 4).| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 16, 2026 | Hougen Elizabeth L Executive | Sell | Common Stock | $14.88M | -206K -66.78% | 102,272 0.06% of shares | high |
| Mar 9, 2026 | Monia Brett P CEO | Sell | Common Stock | $8.85M | -118K -32.49% | 244,346 0.15% of shares | medium |
| Mar 3, 2026 | Bennett C Frank Executive | Sell | Common Stock | $5.66M | -72K -43.23% | 94,043 0.06% of shares | medium |
| Jan 30, 2026 | Monia Brett P CEO | Sell | Common Stock | $5.21M | -63K -18.15% | 283,927 0.17% of shares | medium |
| Mar 9, 2026 | Monia Brett P CEO | Exercise | Common Stock | $4.48M | +74K +24.86% | 369,332 0.22% of shares | low |
| May 4, 2026 | Loscalzo Joseph Director | Sell | Common Stock | $4.46M | -60K -52.38% | 54,111 0.03% of shares | medium |
| Feb 2, 2026 | Bennett C Frank Executive | Sell | Common Stock | $4.04M | -49K -37.72% | 80,293 0.05% of shares | medium |
| Mar 16, 2026 | Hougen Elizabeth L Executive | Exercise | Common Stock | $3.67M | +60K +45.38% | 193,180 0.12% of shares | low |
5%+ ownership events
Schedule 13D / 13G
| Filer | Stance | % of class |
|---|---|---|
| Vanguard Group Inc | Passive13G/A | — |
| Capital World Investors | Passive13G/A | — |
| T. Rowe Price Investment Management, Inc. | Passive13G/A | — |
Securities
via CUSIP / OpenFIGI
| Symbol | Type | CUSIP |
|---|---|---|
| IONS | — | 462222100 |